rTMS as an Intervention for Levodopa-induced Dyskinesia
NCT: NCT06570824 · RECRUITING
Brief Summary
The proposed study investigates the use of repetitive transcranial magnetic stimulation (rTMS) as a treatment for levodopa-induced dyskinesia (LID) in Parkinson's Disease (PD). Specifically, the study aims to determine whether patterned stimulation of the pre-supplementary motor area (pre-SMA) can delay the onset of LID after levodopa intake and reduce LID severity in PD patients. This study will provide critical insights into potential targets for rTMS treatment, optimal rTMS parameters, and the mechanisms underlying LID in Parkinson's disease.
Frequently Asked Questions
What is rTMS as an Intervention for Levodopa-induced Dyskinesia?
rTMS as an Intervention for Levodopa-induced Dyskinesia is a clinical trial registered under NCT06570824. Current status: RECRUITING.
What is the status of NCT06570824?
The current status of NCT06570824 (rTMS as an Intervention for Levodopa-induced Dyskinesia) is: RECRUITING.
When did rTMS as an Intervention for Levodopa-induced Dyskinesia start?
rTMS as an Intervention for Levodopa-induced Dyskinesia started on 2024-08-22.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.